Hologic announces launch of 2D/3D prone biopsy system at ECR

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Hologic has launched its Affirm prone biopsy system in the European market. The system, which boasts both 2D and 3D capabilities for use in image-guided biopsies of the breast, was unveiled at the 2016 European Congress of Radiology.

"As screening and diagnostic technology has advanced with the widespread use of 3D mammography, it has become abundantly clear that prone biopsy technology was lagging behind," said Hologic Division President Pete Valenti said in a press release. "A significantly improved imaging capability and a streamlined workflow will provide healthcare providers with increased confidence for these critical procedures so that they can provide the best patient experience."

The company said the new system allows radiologists to target lesions more efficiently during 3D mammography screening due to its improved workflow and 360-degree coverage of the breast.

Read the full press release here.